Influence of circadian rhythms in tumorigenesis - Role of vanillic acid on liver cancer
- 17 February 2020
- journal article
- research article
- Published by Taylor & Francis in Biological Rhythm Research
- Vol. 51 (2) , 294-300
Abstract
Rhythmicity is observed in transcriptional expression of a wide range of clock-controlled genes which regulate a variety of normal cell functions like cell division and proliferation. The human circadian timing system functions to co-ordinate humoral, physiological, and behavioral mechanism to promote sleep and waking behavior. The rhythms are generated by neural structures in the hypothalamus that function as a biological clock. Modern lifestyle is also turning to be a relevant factor promoting desynchrony, especially in individuals staying for long hours awake during the night and with disturbed sleep patterns. Chronotherapeutics is relatively new concept in medicine. The main goal of chronotherapeutics is the enhancement of the desired effects of medications and control of their adverse effects. This review addresses the role of circadian rhythms in tumorigenesis.Keywords
This publication has 34 references indexed in Scilit:
- Targeted drug delivery for cancer therapy: the other side of antibodiesJournal of Hematology & Oncology, 2012
- Circadian Disruption, Sleep Loss, and Prostate Cancer Risk: A Systematic Review of Epidemiologic StudiesCancer Epidemiology, Biomarkers & Prevention, 2012
- Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathwayJournal of Experimental Medicine, 2011
- The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral ClocksAnnual Review of Physiology, 2010
- Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligaseProceedings of the National Academy of Sciences, 2010
- Metabolism and cancer: the circadian clock connectionNature Reviews Cancer, 2009
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: Inhibition of cell proliferation and induction of apoptosisChemico-Biological Interactions, 2009
- Circadian Rhythms: Mechanisms and Therapeutic ImplicationsAnnual Review of Pharmacology and Toxicology, 2007
- Chronobiology Implications for cancer chemotherapyActa Oncologica, 1995